YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
For Immediate Release Chicago, IL – September 29, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financia…
Monday, September 28, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Mastercard Inc. (MA) and A…
Image source: The Motley Fool. DATE Friday, Aug. 14, 2026 at 9:00 a.m. ET CALL PARTICIPANTS Investor Relations - Joe Diaz President and Chief Executive Officer - Oliver Te Boekhorst Chief Financial Officer - Timothy Fiori Senior Vice Presi…
Key Points Interested in ImmuCell Corporation? Here are five stocks we like better. Strong domestic growth drove results: Second-quarter product sales rose 11.5% year over year to $7.2 million, while net income increased to $1.8 million fr…
PORTLAND, Maine, Aug. 06, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops, manufactures and markets products to improve calf health and productivi…
(RTTNews) - The following biotech stocks touched a 52-wek high on July 10, 2026, driven by key catalysts like encouraging regulatory updates and quarterly results. American Well Corporation (AMWL) American Well, or Amwell, designs and prov…
(RTTNews) - ImmuCell Corporation (ICCC), an animal health biologics company, on Thursday announced second quarter preliminary sales results, marking a 11.55% increase primarily due to significant TriShield sales. The company saw total prod…
ImmuCell (ICCC [https://seekingalpha.com/symbol/ICCC]) on Thursday announced preliminary, unaudited sales results for the second quarter of 2026. Total sales for the three months ended June 30, 2026, were $7.2M, an 11.5% increase compared…
For Immediate Release Chicago, IL – June 26, 2026 – Zacks.com announces the list of stocks and featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial…
Thursday, June 25, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), Novartis AG (NVS) and Qu…
Key Points Interested in ImmuCell Corporation? Here are five stocks we like better. ImmuCell posted a record Q1 2026, with product sales of about $10.4 million, up 28.4% year over year, and net income rising 34% to $1.9 million. Gross marg…
Minot Light Capital Partners, an investment management company, released its “Capital Appreciation Fund" Q1 2026 Investor Letter. A copy of the letter can be downloaded here. The fund declined by 2.7% in the first quarter of 2026 due to a…
For Immediate Releases Chicago, IL – April 22, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial m…
For Immediate Releases Chicago, IL – April 22, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial m…
Tuesday, April 21, 2026 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including The Goldman Sachs Group, Inc. (GS), NextEra Energy,…
ImmuCell Corporation PORTLAND, Maine, April 13, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops and markets products to improve calf health and pr…
PORTLAND, Maine, April 13, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops and markets products to improve calf health and productivity, announced…
ImmuCell Corporation PORTLAND, Maine, March 18, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health biologics company that develops, manufactures and markets products to improve calf…
Shares of ImmuCell Corporation ICCC have declined 0.8% since reporting results for the fourth quarter of 2025. This compares with the S&P 500 index’s 0.7% return over the same time frame. Over the past month, the stock has lost 4.3% compar…
ImmuCell logo Key Points ImmuCell is doubling down on its First Defense calf‑scours franchise while stepping away from the Re‑Tain subclinical mastitis program, taking a roughly $2.7M non‑cash impairment on Re‑Tain‑related assets. Full‑yea…
Earnings Call Insights: ImmuCell Corporation (ICCC) Q4 2025 MANAGEMENT VIEW * P. F. Te Boekhorst, President and CEO, opened by highlighting a successful year, including hiring a new management team, expanding manufacturing capacity, resolv…
PORTLAND, Maine, March 04, 2026 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that develops, manufactures and markets products that improve cattle health and productivity, t…
ImmuCell logo Key Points ImmuCell is shifting its strategy to focus on First Defense and has paused investment in mastitis candidate Re‑Tain after an FDA “Incomplete Letter” tied to an outsourced aseptic‑filling contractor; the company wil…
* ImmuCell press release [https://seekingalpha.com/pr/20358707-immucell-announces-preliminary-unaudited-sales-results-for-q4-and-full-year-of-2025] (ICCC [https://seekingalpha.com/symbol/ICCC]): Q4 Revenue of $7.6M. * * International sales…
For Immediate Releases Chicago, IL – December 26, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financia…
Wednesday, December 24, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV), The Coca-Cola Co. (KO) and…
PORTLAND, Maine, Dec. 24, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell”), an animal health company that develops, manufactures and markets products that improve cattle health and productivity today announced that…
* ImmuCell press release [https://seekingalpha.com/pr/20307319-immucell-announces-unaudited-financial-results-for-the-quarter-ended-september-30-2025] (ICCC [https://seekingalpha.com/symbol/ICCC]): Q3 GAAP EPS of -$0.02. * Revenue of $5.50…
PORTLAND, Maine, Nov. 13, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that…
PORTLAND, Maine, Nov. 04, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that…
For Immediate Release Chicago, IL – October 9, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial m…
Wednesday, October 8, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including SAP SE (SAP), Novartis AG (NVS) and Philip Morris…
ImmuCell Corporation (NASDAQ:ICCC [https://seekingalpha.com/symbol/ICCC]) announced on Tuesday preliminary, unaudited sales results for the third quarter of 2025. Preliminary, Unaudited Total Sales Results: 2025 2024 ($ Decrease) $ Increas…
PORTLAND, Maine, Oct. 07, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that…
* ImmuCell (NASDAQ:ICCC [https://seekingalpha.com/symbol/ICCC]) announced that it has selected Olivier te Boekhorst as its next President and CEO, anticipating a start date of November 1, 2025. * The company said te Boekhorst is currently…
PORTLAND, Maine, Sept. 29, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products tha…